CovalX logo — Protein Interaction Analytics. The accuracy of mass spectrom...

CovalX

Protein Interaction Analytics. The accuracy of mass spectrometry for your biologics project.

Founded 2005 Switzerland Zurich, Switzerland 22 employees Biotechnology, Hardware +3

General Information

Company Name CovalX
Founded Year 2005
Location Switzerland Zurich, Switzerland
Employees 22
Industries Biotechnology, Hardware, Health Care +2
Social

BounceWatch is an independent company data service, not affiliated with CovalX. To contact CovalX, visit covalx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does CovalX compare?

A PDF of CovalX and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting CovalX soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About CovalX

CovalX, established in 2006, is a leader in characterizing protein interactions through mass spectrometry. The company's innovative technologies and exclusive services cater to world-renowned Universities, therapeutic companies, and major pharmaceutical companies globally. CovalX AG specializes in measuring intact protein complexes using MALDI mass spectrometry, offering both tools and services for High-Mass MALDI protein-protein interaction analysis. The applications of their technology span from epitope mapping to characterizing aggregates from biotherapeutic drugs, analyzing antibody-antigen interactions, and rapidly characterizing protein complexes. Additionally, CovalX offers services for characterizing large macro molecules such as PEGylated proteins or polymers. Recently, the company restructured its operations, moving hardware support facilities and US sales and marketing to the Boston area, establishing an official subsidiary there. With a focus on the biotechnology, hardware, health care, pharmaceutical, and marketing industries, CovalX stands at the forefront of protein interaction analytics, employing mass spectrometry with the slogan "Protein Interaction Analytics. The accuracy of mass spectrometry for your biologics project."

Business keywords: Protein Interaction Analytics, Mass Spectrometry, Biologics, High-Mass MALDI, Epitope Mapping, Therapeutic Aggregates, Antibody Characterization, Protein Complex, Amino Acids, Enzymes, Monoclonal Antibody, De Novo Sequencing, Intact MALDI-MS, Epitope Mapping Services, Biotherapeutics

No funding data available for CovalX yet.

CovalX Alternatives & Competitors

CovalX vs

Decode the immune system by sequencing and quantifying antibody proteins. REmAb®, REpAb®, NovorIg™,...

Series A
56 employees
Biotechnology, Health Care
CovalX vs

Comera Life Sciences transforms the formulation of biotherapeutics for the ultimate benefit of patie...

Post-IPO Equity
2 employees
Biotechnology, Health Care

FAQ About CovalX

Protein Interaction Analytics. The accuracy of mass spectrometry for your biologics project.
CovalX was founded in 2005.
CovalX is headquartered in Zurich, Switzerland.
CovalX operates in Biotechnology, Hardware, Health Care, Pharmaceutical and Marketing. Its work centres on Protein Interaction Analytics, Mass Spectrometry, Biologics and High-Mass MALDI.
CovalX has approximately 22 employees.
Top alternatives and competitors to CovalX include Rapid Novor, Comera Life Sciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CovalX and Rapid Novor are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for CovalX, https://bouncewatch.com/company/covalx, updated 24 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes